To this end, we used siRNAs targeting ATG4b (Supplementary Figs. 14a-b) and ATG7 (Supplementary Figs. 14c-d) and assessed the viability of mIDH1 glioma NS treated in combination with radiation. Here, ATG7 is linked to central nervous system cancer.